Is oral methadone better than placebo or other oral/transdermal opioids in the management of pain?
- PMID: 21708855
- DOI: 10.1177/0269216310397687
Is oral methadone better than placebo or other oral/transdermal opioids in the management of pain?
Abstract
Aim: To address the question: is oral methadone better than placebo, or other oral/transdermal opioids in the management of cancer pain?
Method: A literature search was performed to identify relevant studies. Search strategies included: (1) methadone (title) AND placebo (title or abstract) AND pain (title or abstract); (2) methadone (title) AND randomized (title or abstract) AND pain (title or abstract) AND cancer (title or abstract). Papers were reviewed for relevance to first-line opioid therapy.
Results: No studies were identified comparing methadone to placebo for cancer pain. A single study compared methadone to placebo for neuropathic pain and demonstrated evidence of analgesic effect at a dose of 20 mg/day but not at a dose of 10 mg/day. Four studies compared oral methadone to either oral morphine, or oral morphine and transdermal fentanyl in a first-line setting: Gourlay 1986 (N = 18), Ventafridda 1986 (N =54), Bruera 2004 (N = 106) and Mercadante 2008 (N = 108). All studies demonstrated comparable, but not superior, analgesia with, overall, a comparable adverse effect profile. The duration of the study period for the three largest studies was 28 days. Two of these studies, Ventafridda 1986 and Mercadante 2008, indicated that, over time, the opioid escalation index was lower for methadone than for morphine. One study that used a 2:1 dose ratio between morphine and methadone was associated with a high attrition rate in the first week because of excessive sedation. This effect was not seen in the study that used a 4:1 morphine to methadone dose ratio with dose titration.
Conclusion: This limited data suggests that (1) methadone may be an equally effective candidate for first-line opioid therapy, (2) that it is possibly less expensive, (3) that there may be a propensity to sedation and dose accumulation unless there is close monitoring and conservative dose selection and (4) that it should be initiated with a calculated dose based on a morphine to methadone dose ratio of not less than 4:1.
Similar articles
-
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.Eur J Pain. 2008 Nov;12(8):1040-6. doi: 10.1016/j.ejpain.2008.01.013. Epub 2008 Mar 18. Eur J Pain. 2008. PMID: 18353696 Clinical Trial.
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.Cancer. 2004 Dec 15;101(12):2866-73. doi: 10.1002/cncr.20712. Cancer. 2004. PMID: 15529307 Clinical Trial.
-
Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.Cancer. 1998 Mar 15;82(6):1167-73. Cancer. 1998. PMID: 9506365
-
Methadone treatment for pain states.Am Fam Physician. 2005 Apr 1;71(7):1353-8. Am Fam Physician. 2005. PMID: 15832538 Review.
Cited by
-
Methadone in post-herpetic neuralgia: A pilot proof-of-concept study.Clinics (Sao Paulo). 2013 Jul;68(7):1057-60. doi: 10.6061/clinics/2013(07)25. Clinics (Sao Paulo). 2013. PMID: 23917673 Free PMC article. Clinical Trial.
-
Neuropathic Pain in Cancer: What Are the Current Guidelines?Curr Treat Options Oncol. 2024 Sep;25(9):1193-1202. doi: 10.1007/s11864-024-01248-7. Epub 2024 Aug 5. Curr Treat Options Oncol. 2024. PMID: 39102168 Free PMC article. Review.
-
Methadone for Pain Management: A Pharmacotherapeutic Review.CNS Drugs. 2020 Aug;34(8):827-839. doi: 10.1007/s40263-020-00743-3. CNS Drugs. 2020. PMID: 32564328 Review.
-
The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain.J Pain Res. 2021 Jul 16;14:2139-2164. doi: 10.2147/JPR.S315585. eCollection 2021. J Pain Res. 2021. PMID: 34295184 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical